Now showing items 1-5 of 5
Treatment-related toxicities in tumor-bearing cats treated with temozolomide alone or in combination with doxorubicin: a pilot assessment
(Sage Publications Ltd, 2012-08-01)
A retrospective study assessing treatment-related toxicities in tumor-bearing cats treated with temozolomide (TMZ) alone or in combination with doxorubicin was conducted. TMZ was administered orally once a day for 5 days ...
Evaluation of ifosfamide salvage therapy formetastatic canine osteosarcoma
A retrospective study was performed to assess toxicity and response rate of ifosfamide salvage treatment for dogs diagnosed with metastatic osteosarcoma (OSA). Dogs diagnosed with OSA and previously treated with standard ...
Canine tonsillar squamous cell carcinoma - a multi-centre retrospective review of 44 clinical cases
OBJECTIVES: To review the presenting clinical signs, treatment and survival of dogs with tonsillar squamous cell carcinoma and, if possible, to identify useful prognostic indicators. METHODS: Medical records of 44 dogs ...
Combined Gemcitabine and Carboplatin Therapy for Carcinomas in Dogs
(Wiley-Blackwell Publishing, Inc, 2009-01-01)
Background: Response and adverse reactions to combined gemcitabine (GEM) and carboplatin (CARBO) therapy in dogs with carcinomas are not documented. Hypothesis: GEM and CARBO are safe for the treatment of dogs with ...
Treatment with DAV for Advanced-Stage Hemangiosarcoma in Dogs
(Amer Animal Hospital Assoc, 2011-05-01)
Hemangiosarcoma (HSA) is an aggressive disease that is fairly common in the dog. The authors evaluated a doxorubicin, dacarbazine, and vincristine (DAV) combination protocol in dogs with nonresectable stage II and stage ...